Hidden terms surface in Trump-era drug-pricing pacts with Pfizer and Lilly
TL;DR
Exclusive Washington Post documents show the Trump administration’s confidential drug-pricing deals with Pfizer and Eli Lilly included inducements to raise prices overseas, tariff protections, and broad confidentiality clauses, with redactions prompting scrutiny and a challenge by Public Citizen over the terms’ value to patients.
- Secret contracts reveal undisclosed terms in Trump’s drug-pricing deals The Washington Post
- Trump announces all 50 states are joining Medicaid drug pricing model AP News
- Trump Promotes Program to Reduce Medicaid Drug Prices The New York Times
- A year ago, President Trump pledged to lower Medicaid drug prices. Has that happened? NPR
- President Trump Extends Most Favored Nation Drug Pricing to Every Medicaid Program in America The White House (.gov)
Want the full story? Read the original reporting
Read on The Washington Post